OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
June 06, 2024
An analysis of the general medicine portion of the pharmacy market amid ensuing challenges.
The latest news for pharma industry insiders.
June 05, 2024
The development and manufacturing plant will be constructed in Texas, and is expected to become operational by Q1 2025.
The courts reversed certain key guidance documents issued by the Health Resources and Services Administration for the 340B Program, which raises uncertainty.
June 04, 2024
The new plant in Italy is expected to tackle the rise in biopharmaceutical material demand, specifically for GLP-1s.
A retrospective study explores the connection between adherence and racial/ethnic disparities among patients with Alzheimer’s disease, along with similar dementias.
June 03, 2024
The Netherlands plant is expected to provide solutions that can help further the development of advanced therapies.
In an interview with Pharma Commerce Editor Nicholas Saraceno, Lung-I Cheng, PhD, VP, Head of Cell & Gene Therapy Service Line, Cencora offers his thoughts on Cencora's inaugural ThinkLive Cell and Gene Therapy Summit.